Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Amgen’s TVEC Vaccine Shows Promise in Regional Melanoma, Greater Benefit and Applicability in Question
Sept. 4, 2012
Amgen’s therapeutic vaccine, TVEC, shows promise in controlling regional melanoma, experts told BioPharm Insight. However, they questioned whether the injectable therapy would be effective in treating distal tumors in the liver, brain, and lungs.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing